MedTrace Pharma A/S: Financial statements 2019
CVR: 36497661
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,060,541 and a net result of DKK -1,001,671 compared with DKK -1,236,840 the year before. Equity in the 2019 report amounted to DKK 5,735,058. The solvency ratio was 15.5%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,060,541
- Profit/Loss
- DKK -1,001,671
- Equity
- DKK 5,735,058
- Total Assets
- DKK 37,008,715
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.1 mio. | -1 mio. | 5.7 mio. | 5 |
| 2018 | - | -68 t. | -1.2 mio. | 6.7 mio. | 5 |
| 2017 | - | -2.2 mio. | -2 mio. | 2.4 mio. | 5 |
| 2016 | - | 1.5 mio. | 1.2 mio. | 4.2 mio. | 4 |
| 2015 | - | -232.4 mio. | -245.5 mio. | 2.8 mia. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MedTrace Pharma A/S has published its annual report for 2018. Gross profit came to DKK -68,239, and the net result was DKK -1,236,840.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.